ICOUGH Bundle and Postoperative Pain and Nausea After Laparoscopic Cholecystectomy
Launched by ATATURK UNIVERSITY · Dec 24, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific care program called the ICOUGH Bundle on pain and nausea after a laparoscopic cholecystectomy, which is a minimally invasive surgery to remove the gallbladder. The trial will take place at Atatürk University Research Hospital from December 2024 to September 2025 and will involve adult patients aged 18 and older who are scheduled for this surgery. Participants need to be in good health without any physical or mental limitations that could interfere with breathing exercises, and they must be able to communicate effectively.
If you choose to participate, you will be approached the day before your surgery to discuss the study and provide your consent if you agree to join. The trial will collect information about your pain and nausea levels after surgery using simple questionnaires. It's important to know that if you experience any severe complications during or after surgery, such as heavy bleeding or difficulty breathing, you will not be included in the study. This research aims to improve postoperative care and help enhance recovery for patients undergoing this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those who agree to participate in the study and volunteer
- • Aged 18 and above
- • Undergoing laparoscopic cholecystectomy surgery under general anesthesia
- • Those without physical or mental disabilities, limitations, or conditions that would prevent them from performing respiratory exercises (such as the use of medications affecting respiration, conditions requiring oxygen therapy, etc.)
- • Those whose cognitive level is suitable for the application of scales
- • Patients without communication problems will be included in the study
- Exclusion Criteria:
- • Those whose hemodynamic values are not stable after the surgical intervention
- • Those who develop any complications such as severe bleeding, nausea, vomiting, etc., after surgery
- • Patients with acute or chronic lung diseases
- • Patients who voluntarily wish to withdraw from the study will not be included in the study
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported